High-Dose Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer That Has Been Removed During Surgery

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 1998

Study Completion Date

September 30, 2007

Conditions
Ovarian Cancer
Interventions
BIOLOGICAL

filgrastim

DRUG

carboplatin

DRUG

cyclophosphamide

DRUG

melphalan

DRUG

paclitaxel

PROCEDURE

adjuvant therapy

PROCEDURE

bone marrow ablation with stem cell support

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (17)

6000

Centre Hospitalier Notre Dame - Reine Fabiola, Charleroi

10034

Charles University, Prague

14000

Thomayer Memorial Teaching Hospital, Prague

28040

Hospital Universitario San Carlos, Madrid

36100

Ospedale San Bortolo, Vicenza

40138

Azienda Ospedaliera Di Bologna Policlinico S. Orsola - Malpighi, Bologna

46010

Hospital Clinico Universitario de Valencia, Valencia

56100

Ospedale Santa Chiara, Pisa

76133

Staedt Klinikum Karlsruhe GGMBH, Karlsruhe

A-1220

Sozialmedizinisches Zentrum Ost - Donauspital, Vienna

D-90419

Klinikum Nuernberg - Klinikum Nord, Nuremberg

00152

S. Camillo Hospital, Rome

833 10

National Cancer Institute - Bratislava, Bratislava

CH-1011

Centre Hospitalier Universitaire Vaudois, Lausanne

LS9 7TF

Leeds Cancer Centre at St. James's University Hospital, Leeds

NW1 2ND

Cancer Research UK and University College London Cancer Trials Centre, London

M20 9BX

Cancer Research Centre at Weston Park Hospital, Manchester

All Listed Sponsors
lead

EBMT Solid Tumors Working Party

OTHER

NCT00004921 - High-Dose Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer That Has Been Removed During Surgery | Biotech Hunter | Biotech Hunter